CD28 costimulatory signals in T lymphocyte activation: Emerging functions beyond a qualitative and quantitative support to TCR signalling

Cytokine and Growth Factor Reviews

Volumn 28, Issue , 2016, Pages 11-19

  Porciello, Nicla ^a   Tuosto, Loretta ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

CD28; Cytokines; Inflammation; NF B; T cells

Indexed keywords

CD28 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; T LYMPHOCYTE RECEPTOR; CYTOKINE; LYMPHOCYTE ANTIGEN RECEPTOR;

CARBOXY TERMINAL SEQUENCE; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; SEQUENCE ANALYSIS; SHORT SURVEY; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; ANIMAL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD28; CYTOKINES; HUMANS; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84959899676     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2016.02.004     Document Type: Review

References (130)

1. Aruffo A., Seed B. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:8573-8577.
2. Gross J.A., St John T., Allison J.P. The murine homologue of the T lymphocyte antigen CD28: molecular cloning and cell surface expression. J. Immunol. 1990, 144:3201-3210.
3. Freeman G.J., Gribben J.G., Boussiotis V.A., Ng J.W., Restivo V.A., Lombard L.A., et al. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 1993, 262:909-911.
4. Linsley P.S., Greene J.L., Brady W., Bajorath J., Ledbetter J.A., Peach R. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1994, 1:793-801.
5. Yao S., Zhu Y., Zhu G., Augustine M., Zheng L., Goode D.J., et al. B7-h2 is a costimulatory ligand for CD28 in human. Immunity 2011, 34:729-740.
6. Acuto O., Michel F. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat. Rev. Immunol. 2003, 3:939-951.
7. Manickasingham S.P., Anderton S.M., Burkhart C., Wraith D.C. Qualitative and quantitative effects of CD28/B7-mediated costimulation on naive T cells in vitro. J. Immunol. 1998, 161:3827-3835.
8. Boomer J.S., Green J.M. An enigmatic tail of CD28 signaling. Cold Spring Harb Perspect Biol. 2010, 2:a002436.
9. Camperio C., Muscolini M., Volpe E., Di Mitri D., Mechelli R., Buscarinu M.C., et al. CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes. Immunol. Lett. 2014, 158:134-142.
10. Diehn M., Alizadeh A.A., Rando O.J., Liu C.L., Stankunas K., Botstein D., et al. Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:11796-11801.
11. Marinari B., Costanzo A., Marzano V., Piccolella E., Tuosto L. CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters. Proc Natl Acad Sci U. S. A. 2004, 101:6098-6103.
12. Raab M., Pfister S., Rudd C.E. CD28 signaling via VAV/SLP-76 adaptors: regulation of cytokine transcription independent of TCR ligation. Immunity 2001, 15:921-933.
13. Riley J.L., Mao M., Kobayashi S., Biery M., Burchard J., Cavet G., et al. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:11790-11795.
14. Schwartz R.H. T cell anergy. Annu. Rev. Immunol. 2003, 21:305-334.
15. Harding F.A., McArthur J.G., Gross J.A., Raulet D.H., Allison J.P. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature. 1992, 356:607-609.
16. Viola A., Lanzavecchia A. T cell activation determined by T cell receptor number and tunable thresholds. Science 1996, 273:104-106.
17. Michel F., Attal-Bonnefoy G., Mangino G., Mise-Omata S., Acuto O. CD28 as a molecular amplifier extending TCR ligation and signaling capabilities. Immunity 2001, 15:935-945.
18. Acuto O., Cantrell D. T cell activation and the cytoskeleton. Annu. Rev. Immunol. 2000, 18:165-184.
19. Viola A., Schroeder S., Sakakibara Y., Lanzavecchia A. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 1999, 283:680-682.
20. Viola A., Contento R.L., Molon B. Signaling amplification at the immunological synapse. Curr. Top. Microbiol. Immunol. 2010, 340:109-122.
21. Tuosto L., Acuto O. CD28 affects the earliest signaling events generated by TCR engagement. Eur. J. Immunol. 1998, 28:2132-2142.
22. Zhang W., Samelson L.E. The role of membrane-associated adaptors in T cell receptor signalling. Semin. Immunol. 2000, 12:35-41.
23. Gwack Y., Feske S., Srikanth S., Hogan P.G., Rao A. Signalling to transcription: store-operated Ca2+ entry and NFAT activation in lymphocytes. Cell Calcium 2007, 42:145-156.
24. Li Y., Sedwick C.E., Hu J., Altman A. Role for protein kinase Ctheta (PKCtheta) in TCR/CD28-mediated signaling through the canonical but not the non-canonical pathway for NF-kappaB activation. J. Biol. Chem. 2005, 280:1217-1223.
25. Sun Z., Arendt C.W., Ellmeier W., Schaeffer E.M., Sunshine M.J., Gandhi L., et al. PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature 2000, 404:402-407.
26. Villalba M., Bi K., Hu J., Altman Y., Bushway P., Reits E., et al. Translocation of PKC[theta] in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C. J. Cell Biol. 2002, 157:253-263.
27. Kane L.P., Lin J., Weiss A. Signal transduction by the TCR for antigen. Curr. Opin. Immunol. 2000, 12:242-249.
28. Nunes J.A., Battifora M., Woodgett J.R., Truneh A., Olive D., Cantrell D.A. CD28 signal transduction pathways. A comparison of B7-1 and B7-2 regulation of the map kinases: ERK2 and Jun kinases. Mol. Immunol. 1996, 33:3-70.
29. Su B., Jacinto E., Hibi M., Kallunki T., Karin M., Ben-Neriah Y. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 1994, 77:727-736.
30. Appleman L.J., van Puijenbroek A.A., Shu K.M., Nadler L.M., Boussiotis V.A. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. J. Immunol. 2002, 168:2729-2736.
31. Boonen G.J., van Dijk A.M., Verdonck L.F., van Lier R.A., Rijksen G., Medema R.H. CD28 induces cell cycle progression by IL-2-independent down-regulation of p27kip1 expression in human peripheral T lymphocytes. Eur. J. Immunol. 1999, 29:789-798.
32. Frauwirth K.A., Riley J.L., Harris M.H., Parry R.V., Rathmell J.C., Plas D.R., et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 2002, 16:769-777.
33. Kim H.P., Imbert J., Leonard W.J. Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. Cytokine Growth Factor Rev. 2006, 17:349-366.
34. Fraser J.D., Irving B.A., Crabtree G.R., Weiss A. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 1991, 251:313-316.
35. Lindstein T., June C.H., Ledbetter J.A., Stella G., Thompson C.B. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 1989, 244:339-343.
36. Shapiro V.S., Truitt K.E., Imboden J.B., Weiss A. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites. Mol. Cell. Biol. 1997, 17:4051-4058.
37. Verweij C.L., Geerts M., Aarden L.A. Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-kB-like response element. J. Biol. Chem. 1991, 266:14179-14182.
38. Pei Y., Zhu P., Dang Y., Wu J., Yang X., Wan B., et al. Nuclear export of NF90 to stabilize IL-2 mRNA is mediated by AKT-dependent phosphorylation at Ser647 in response to CD28 costimulation. J. Immunol. 2008, 180:222-229.
39. Shim J., Lim H., Yates J.R., Karin M. Nuclear export of NF90 is required for interleukin-2 mRNA stabilization. Mol. Cell 2002, 10:1331-1344.
40. Ogilvie R.L., Abelson M., Hau H.H., Vlasova I., Blackshear P.J., Bohjanen P.R. Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay. J. Immunol. 2005, 174:953-961.
41. Cianfrocca R., Muscolini M., Marzano V., Annibaldi A., Marinari B., Levrero M., et al. RelA/NF-kappaB recruitment on the bax gene promoter antagonizes p73-dependent apoptosis in costimulated T cells. Cell Death Differ. 2008, 15:354-363.
42. Tuosto L. NF-kappaB family of transcription factors: biochemical players of CD28 co-stimulation. Immunol. Lett. 2011, 135:1-9.
43. Muscolini M., Camperio C., Porciello N., Caristi S., Capuano C., Viola A., et al. Phosphatidylinositol 4-phosphate 5-kinase alpha and vav1 mutual cooperation in cd28-mediated actin remodeling and signaling functions. J. Immunol. 2015, 194:1323-1333.
44. Muscolini M., Sajeva A., Caristi S., Tuosto L. A novel association between filamin A and NF-kappaB inducing kinase couples CD28 to inhibitor of NF-kappaB kinase alpha and NF-kappaB activation. Immunol. Lett. 2011, 36:203-212.
45. Piccolella E., Spadaro F., Ramoni C., Marinari B., Costanzo A., Levrero M., et al. Vav-1 and the IKK alpha subunit of I kappa B kinase functionally associate to induce NF-kappa B activation in response to CD28 engagement. J. Immunol. 2003, 170:2895-2903.
46. Tavano R., Contento R.L., Baranda S.J., Soligo M., Tuosto L., Manes S., et al. CD28 interaction with filamin-A controls lipid raft accumulation at the T-cell immunological synapse. Nat. Cell. Biol. 2006, 8:1270-1276.
47. Michel F., Acuto O. CD28 costimulation: a source of Vav-1 for TCR signaling with the help of SLP-76?. Sci. STKE 2002, 144:pe35.
48. Rudd C.E., Raab M. Independent CD28 signaling via VAV and SLP-76: a model for in trans costimulation. Immunol. Rev. 2003, 192:32-41.
49. Schneider H., Rudd C.E. CD28 and Grb-2, relative to Gads or Grap, preferentially co-operate with Vav1 in the activation of NFAT/AP-1 transcription. Biochem. Biophys. Res. Commun. 2008, 369:616-621.
50. Thaker Y.R., Schneider H., Rudd C.E. TCR and CD28 activate the transcription factor NF-kappaB in T-cells via distinct adaptor signaling complexes. Immunol. Lett. 2015, 163:113-119.
51. Barda-Saad M., Shirasu N., Pauker M.H., Hassan N., Perl O., Balbo A., et al. Cooperative interactions at the SLP-76 complex are critical for actin polymerization. EMBO J. 2010, 29:2315-2328.
52. Lettau M., Pieper J., Janssen O. Nck adapter proteins: functional versatility in T cells. Cell. Commun. Signal. 2009, 7:1.
53. Stossel T.P., Condeelis J., Cooley L., Hartwig J.H., Noegel A., Schleicher M., et al. Filamins as integrators of cell mechanics and signalling. Nat. Rev. Mol. Cell. Biol. 2001, 2:138-145.
54. Zhou A.X., Hartwig J.H., Akyurek L.M. Filamins in cell signaling, transcription and organ development. Trends Cell Biol. 2010, 20:113-123.
55. Hayashi K., Altman A. Filamin A is required for T cell activation mediated by protein kinase C-theta. J. Immunol. 2006, 177:1721-1728.
56. Saarikangas J., Zhao H., Lappalainen P. Regulation of the actin cytoskeleton-plasma membrane interplay by phosphoinositides. Physiol. Rev. 2010, 90:259-289.
57. Tuosto L., Capuano C., Muscolini M., Santoni A., Galandrini R. The multifaceted role of PIP2 in leukocyte biology. Cell. Mol. Life Sci. 2015, 72:4461-4474.
58. Kallikourdis M., Trovato A.E., Roselli G., Muscolini M., Porciello N., Tuosto L., et al. Phosphatidylinositol 4-phosphate 5-kinase β controls recruitment of lipid rafts into the immunological synapse. J. Immunol. 2016, 2016(196):1955-1963.
59. Muscolini M., Camperio C., Capuano C., Caristi S., Piccolella E., Galandrini R., et al. Phosphatidylinositol 4-phosphate 5-kinase alpha activation critically contributes to CD28-dependent signaling responses. J. Immunol. 2013, 190:5279-5286.
60. Schmitz M.L., Krappmann D. Controlling NF-kappaB activation in T cells by costimulatory receptors. Cell Death Differ. 2006, 13:834-842.
61. Vallabhapurapu S., Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 2009, 27:693-733.
62. Luo J.L., Kamata H., Karin M. IKK/NF-kappaB signaling: balancing life and death-a new approach to cancer therapy. J. Clin. Invest. 2005, 115:2625-2632.
63. Rebeaud F., Hailfinger S., Posevitz-Fejfar A., Tapernoux M., Moser R., Rueda D., et al. The proteolytic activity of the paracaspase MALT1 is key in T cell activation. Nat. Immunol. 2008, 9:272-281.
64. Tanner M.J., Hanel W., Gaffen S.L., Lin X. CARMA1 coiled-coil domain is involved in the oligomerization and subcellular localization of CARMA1 and is required for T cell receptor-induced NF-kappaB activation. J. Biol. Chem. 2007, 282:17141-17147.
65. Wang D., Matsumoto R., You Y., Che T., Lin X.Y., Gaffen S.L., et al. CD3/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1. Mol. Cell. Biol. 2004, 24:164-171.
66. Marinari B., Costanzo A., Viola A., Michel F., Mangino G., Acuto O., et al. Vav cooperates with CD28 to induce NF-kappaB activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1. Eur. J. Immunol. 2002, 32:447-456.
67. Tuosto L., Costanzo A., Guido F., Marinari B., Vossio S., Moretti F., et al. Mitogen-activated kinase kinase kinase 1 regulates T cell receptor- and CD28-mediated signaling events which lead to NF-kappaB activation. Eur. J. Immunol. 2000, 30:2445-2454.
68. Harhaj E.W., Sun S.C. IkappaB kinases serve as a target of CD28 signaling. J. Biol. Chem. 1998, 273:25185-25190.
69. Lai J.H., Tan T.H. CD28 signaling causes a sustained down-regulation of I kappa B alpha which can be prevented by the immunosuppressant rapamycin. J. Biol. Chem. 1994, 269:30077-30080.
70. Sanchez-Lockhart M., Marin E., Graf B., Abe R., Harada Y., Sedwick C.E., et al. Cutting edge: CD28-mediated transcriptional and posttranscriptional regulation of IL-2 expression are controlled through different signaling pathways. J. Immunol. 2004, 173:7120-7124.
71. Annibaldi A., Sajeva A., Muscolini M., Ciccosanti F., Corazzari M., Piacentini M., et al. CD28 ligation in the absence of TCR promotes RelA/NF-kB recruitment and trans-activation of the HIV-1 LTR. Eur. J. Immunol. 2008, 38:1446-1451.
72. Jadidi-Niaragh F., Mirshafiey A. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand. J. Immunol. 2011, 74:1-13.
73. Edwards L.J., Sharrack B., Ismail A., Tumani H., Constantinescu C.S. Central inflammation versus peripheral regulation in multiple sclerosis. J. Neurol. 2011, 258:1518-1527.
74. Ysrraelit M.C., Gaitan M.I., Lopez A.S., Correale J. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis. Neurology 2008, 71:1948-1954.
75. Ghigo A., Damilano F., Braccini L., Hirsch E. PI3 K inhibition in inflammation: Toward tailored therapies for specific diseases. Bioessays 2010, 32:185-196.
76. Delgoffe G.M., Pollizzi K.N., Waickman A.T., Heikamp E., Meyers D.J., Horton M.R., et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat. Immunol. 2011, 12:295-303.
77. Shi L.Z., Wang R., Huang G., Vogel P., Neale G., Green D.R., et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 2011, 208:1367-1376.
78. Lenschow D.J., Herold K.C., Rhee L., Patel B., Koons A., Qin H.Y., et al. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 1996, 5:285-293.
79. Miller S.D., Vanderlugt C.L., Lenschow D.J., Pope J.G., Karandikar N.J., Dal Canto M.C., et al. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 1995, 3:739-745.
80. Pollard K.M., Arnush M., Hultman P., Kono D.H. Costimulation requirements of induced murine systemic autoimmune disease. J. Immunol. 2004, 173:5880-5887.
81. Tai X., Van Laethem F., Sharpe A.H., Singer A. Induction of autoimmune disease in CTLA-4-/- mice depends on a specific CD28 motif that is required for in vivo costimulation. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13756-13761.
82. Riha P., Rudd C.E. CD28 co-signaling in the adaptive immune response. Self Nonself 2010, 1:231-240.
83. Marengère L.E., Okkenhaug K., Clavreul A., Couez D., Gibson S., Mills G.B., et al. The SH3 domain of Itk/Emt binds to proline-rich sequences in the cytoplasmic domain of the T cell costimulatory receptor CD28. J. Immunol. 1997, 159:3220-3229.
84. Holdford A.D., Green J.M., Levin S.D., Denny M.F., Straus D.B., Link P.S., et al. Proline residues in CD28 and the Src homology (SH) 3 domain of Lck are required for T cell costimulation. J. Exp. Med. 1999, 190:375-384.
85. Tavano R., Gri G., Molon B., Marinari B., Rudd C.E., Tuosto L., et al. CD28 and lipid rafts coordinate recruitment of Lck to the immunological synapse of human T lymphocytes. J. Immunol. 2004, 173:5392-5397.
86. Kim H.H., Tharayil M., Rudd C.E. Growth factor receptor-bound protein 2 SH2/SH3 domain binding to CD28 and its role in co-signaling. J. Biol. Chem. 1998, 273:296-301.
87. King P.D., Sadra A., Teng J.M., Xiao-Rong L., Han A., Selvakumar A., et al. Analysis of CD28 cytoplasmic tail tyrosine residues as regulators and substrates for the protein tyrosine kinases, EMT and LCK. J. Immunol. 1997, 158:580-590.
88. Raab M., Cai Y.C., Bunnell S.C., Heyeck S.D., Berg L.J. Rudd CE. p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulation. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:8891-8895.
89. August A., Dupont B. CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase. Int. Immunol. 1994, 6:769-774.
90. Cai Y.C., Cefai D., Schneider H., Raab M., Nabavi N., Rudd C.E. Selective CD28pYMNM mutations implicate phosphatidylinositol 3-kinase in CD86-CD28-mediated costimulation. Immunity 1995, 3:417-426.
91. Pages F., Ragueneau M., Rottapel R., Truneh A., Nunes J., Imbert J., et al. Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling. Nature 1994, 369:327-329.
92. Prasad K.V., Cai Y.C., Raab M., Duckworth B., Cantley L., Shoelson S.E., et al. T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:2834-2838.
93. Lemmon M.A. Pleckstrin homology domains: two halves make a hole. Cell 2005, 120:574-576.
94. Lee K.Y., D'Acquisto F., Hayden M.S., Shim J.H., Ghosh S. PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation. Science 2005, 308:114-118.
95. Yokosuka T., Kobayashi W., Sakata-Sogawa K., Takamatsu M., Hashimoto-Tane A., Dustin M.L., et al. Spatiotemporal regulation of T cell costimulation by TCR-CD28 microclusters and protein kinase C theta translocation. Immunity 2008, 29:589-601.
96. Okkenhaug K., Patton D.T., Bilancio A., Garcon F., Rowan W.C., Vanhaesebroeck B. The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells. J. Immunol. 2006, 177:5122-5128.
97. Park S.G., Schulze-Luehrman J., Hayden M.S., Hashimoto N., Ogawa W., Kasuga M., et al. The kinase PDK1 integrates T cell antigen receptor and CD28 coreceptor signaling to induce NF-kappaB and activate T cells. Nat. Immunol. 2009, 10:158-166.
98. Bauer B., Krumbock N., Fresser F., Hochholdinger F., Spitaler M., Simm A., et al. Complex formation and cooperation of protein kinase C theta and Akt1/protein kinase B alpha in the NF-kappa B transactivation cascade in Jurkat T cells. J. Biol. Chem. 2001, 276:31627-31634.
99. Narayan P., Holt B., Tosti R., Kane L.P. CARMA1 is required for Akt-mediated NF-kappaB activation in T cells. Mol. Cell. Biol. 2006, 26:2327-2336.
100. Kane L.P., Abdres P.G., Howland K.C., Abbas A.K., Weiss A. Akt provides the CD28 costimulatory signal for up-reulation of IL-2 and IFN-gamma but not TH2 cytokines. Nat. Immunol. 2001, 2:37-44.
101. Parry R.V., Reif G., Smith D.M., Sanson B.A., Hemmings B.A., Ward S.G. Ligation of the T cell co-stimulatory receptor CD28 activates the serin-threonin protein kinase B. Eur. J. Immunol. 1997, 27:2495-2501.
102. Kane L.P., Mollenauer M.N., Xu Z., Turck C.W., Weiss A. Akt-dependent phosphorylation specifically regulates Cot induction of NF-kappa B-dependent transcription. Mol. Cell. Biol. 2002, 22:5962-5974.
103. Lin X., Cunningham E.T., Mu Y., Geleziunas R., Greene W.C. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kappaB acting through the NF-kappaB-inducing kinase and IkappaB kinases. Immunity 1999, 10:271-280.
104. Sanchez-Valdepenas C., Martin A.G., Ramakrishnan P., Wallach D., Fresno M. NF-kappaB-inducing kinase is involved in the activation of the CD28 responsive element through phosphorylation of c-Rel and regulation of its transactivating activity. J. Immunol. 2006, 176:4666-4674.
105. Sanchez-Valdepenas C., Punzon C., San-Antonio B., Martin A.G., Fresno M. Differential regulation of p65 and c-Rel NF-kappaB transactivating activity by Cot, protein kinase C zeta and NIK protein kinases in CD3/CD28 activated T cells. Cell. Signal. 2007, 19:528-537.
106. Burr J.S., Savage N.D., Messah G.E., Kimzey S.L., Shaw A.S., Arch R.H., et al. Cutting edge: distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL. J. Immunol. 2001, 166:5331-5335.
107. Jones R.G., Parsons M., Bonnard M., Chan V.S., Yeh W.C., Woodgett J.R., et al. Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo. J. Exp. Med. 2000, 191:1721-1734.
108. Beals C.R., Sheridan C.M., Turck C.W., Gardner P., Crabtree G.R. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 1997, 275:1930-1934.
109. Dodson L.F., Boomer J.S., Deppong C.M., Shah D.D., Sim J., Bricker T.L., et al. Targeted knock-in mice expressing mutations of CD28 reveal an essential pathway for costimulation. Mol. Cell. Biol. 2009, 29:3710-3721.
110. August A., Gibson S., Kawakami Y., Kawakami T., Mills G.B., Dupont B. CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:9347-9351.
111. Li C.R., Berg L.J. Itk is not essential for CD28 signaling in naive T cells. J. Immunol. 2005, 174:4475-4479.
112. Rudd C.E., Taylor A., Schneider H. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol. Rev. 2009, 229:12-26.
113. Yang W.C., Ghiotto M., Barbarat B., Olive D. The role of Tec protein-tyrosine kinase in T cell signaling. J. Biol. Chem. 1999, 274:607-617.
114. Sanchez-Lockhart M., Graf B., Miller J. Signals and sequences that control CD28 localization to the central region of the immunological synapse. J. Immunol. 2008, 181:7639-7648.
115. Watanabe R., Harada Y., Takeda K., Takahashi J., Ohnuki K., Ogawa S., et al. Grb2 and Gads exhibit different interactions with CD28 and play distinct roles in CD28-mediated costimulation. J. Immunol. 2006, 177:1085-1091.
116. Michel F., Mangino G., Attal-Bonnefoy G., Tuosto L., Alcover A., Roumier A., et al. CD28 utilizes Vav-1 to enhance TCR-proximal signaling and NF-AT activation. J. Immunol. 2000, 165:3820-3829.
117. Okkenhaug K., Rottapel R. Grb2 forms an inducible protein complex with CD28 through a Src homology 3 domain-proline interaction. J. Biol. Chem. 1998, 273:21194-21202.
118. Nishida M., Nagata K., Hachimori Y., Horiuchi M., Ogura K., Mandiyan V., et al. Novel recognition mode between Vav and Grb2 SH3 domains. EMBO J. 2001, 20:2995-3007.
119. Ramos-Morales F., Druker B.J., Fischer S. Vav binds to several SH2/SH3 containing proteins in activated lymphocytes. Oncogene 1994, 9:1917-1923.
120. Rivera G.M., Vasilescu D., Papayannopoulos V., Lim W.A., Mayer B.J. A reciprocal interdependence between Nck and PI(4,5)P(2) promotes localized N-WASp-mediated actin polymerization in living cells. Mol. Cell 2009, 36:525-535.
121. Rudd C.E., Schneider H. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat. Rev. Immunol. 2003, 3:544-556.
122. Lin C.H., Hunig T. Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur. J. Immunol. 2003, 33:626-638.
123. Suntharalingam G., Perry M.R., Ward S., Brett S.J., Castello-Cortes A., Brunner M.D., et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N. Engl. J. Med. 2006, 355:1018-1028.
124. Schraven B., Kalinke U. CD28 superagonists: what makes the difference in humans. Immunity 2008, 28:591-595.
125. Waibler Z., Sender L.Y., Merten C., Hartig R., Kliche S., Gunzer M., et al. Signaling signatures and functional properties of anti-human CD28 superagonistic antibodies. PLoS One 2008, 3:e1708.
126. Chen C.H., Piraner D., Gorenstein N.M., Geahlen R.L., Beth Post C. Differential recognition of syk-binding sites by each of the two phosphotyrosine-binding pockets of the Vav SH2 domain. Biopolymers 2013, 99:897-907.
127. Huang H., Li L., Wu C., Schibli D., Colwill K., Ma S., et al. Defining the specificity space of the human SRC homology 2 domain. Mol. Cell. Proteomics 2008, 7:768-784.
128. O'Rourke L.M., Tooze R., Turner M., Sandoval D.M., Carter R.H., Tybulewicz V.L., et al. CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. Immunity 1998, 8:635-645.
129. Songyang Z., Shoelson S.E., McGlade J., Olivier P., Pawson T., Bustelo X.R., et al. Mol. Cell. Biol. 1994, 14:2777-2785.
130. Tuosto L., Michel F., Acuto O. p95vav associates with tyrosine-phosphorylated SLP-76 in antigen-stimulated T cells. J. Exp. Med. 1996, 184:1161-1166.